P.-B. Andersson

1.8k total citations
16 papers, 1.4k citations indexed

About

P.-B. Andersson is a scholar working on Neurology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, P.-B. Andersson has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in P.-B. Andersson's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Immune Response and Inflammation (5 papers) and Multiple Sclerosis Research Studies (4 papers). P.-B. Andersson is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Immune Response and Inflammation (5 papers) and Multiple Sclerosis Research Studies (4 papers). P.-B. Andersson collaborates with scholars based in United States, United Kingdom and Netherlands. P.-B. Andersson's co-authors include V. Hugh Perry, Siamon Gordon, Sharon Gordon, Emmanuelle Waubant, Donald E. Goodkin, Lauren Gee, D Goodkin, R. Sloan, Thomas Stewart and Karen Miller and has published in prestigious journals such as The Journal of Experimental Medicine, Neurology and Neuroscience.

In The Last Decade

P.-B. Andersson

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.-B. Andersson United States 15 618 369 304 302 300 16 1.4k
Vijayabalan Balasingam Canada 12 551 0.9× 429 1.2× 580 1.9× 248 0.8× 236 0.8× 13 1.6k
Eunice E. Kwon United States 13 545 0.9× 282 0.8× 481 1.6× 337 1.1× 916 3.1× 17 1.8k
Cassandra Flügel‐Koch Germany 16 505 0.8× 484 1.3× 521 1.7× 170 0.6× 305 1.0× 20 1.7k
Francesca Ruffini Italy 21 571 0.9× 566 1.5× 665 2.2× 170 0.6× 341 1.1× 30 1.7k
Lyne Bourbonnière Canada 21 877 1.4× 590 1.6× 792 2.6× 291 1.0× 330 1.1× 31 2.1k
Christiane Wegner Germany 21 635 1.0× 408 1.1× 543 1.8× 247 0.8× 1.1k 3.8× 32 2.2k
Camelia‐Maria Monoranu Germany 20 241 0.4× 331 0.9× 402 1.3× 155 0.5× 221 0.7× 54 1.4k
Katarzyna Biernacki Canada 15 481 0.8× 399 1.1× 182 0.6× 106 0.4× 255 0.8× 19 1.1k
Karolina Wosik Canada 15 1.0k 1.6× 552 1.5× 699 2.3× 223 0.7× 224 0.7× 23 2.1k
Mathias Buttmann Germany 26 223 0.4× 492 1.3× 506 1.7× 210 0.7× 390 1.3× 50 1.7k

Countries citing papers authored by P.-B. Andersson

Since Specialization
Citations

This map shows the geographic impact of P.-B. Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.-B. Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.-B. Andersson more than expected).

Fields of papers citing papers by P.-B. Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.-B. Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.-B. Andersson. The network helps show where P.-B. Andersson may publish in the future.

Co-authorship network of co-authors of P.-B. Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of P.-B. Andersson. A scholar is included among the top collaborators of P.-B. Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.-B. Andersson. P.-B. Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lin, Peter, P.-B. Andersson, B. Jane Distad, et al.. (2005). Bilateral isolated phrenic neuropathy causing painless bilateral diaphragmatic paralysis. Neurology. 65(9). 1499–1501. 16 indexed citations
2.
Andersson, P.-B., Eric Yuen, Karen Parko, & Yuen T. So. (2000). Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology. 54(1). 40–40. 87 indexed citations
3.
Goodkin, Donald E., J L Winkelhake, Emmanuelle Waubant, et al.. (2000). A phase I trial of solubilized DR2:MBP 84-102 (AG284) in multiple sclerosis. Neurology. 54(7). 1414–1420. 50 indexed citations
4.
Suhy, Joyce, William D. Rooney, Donald E. Goodkin, et al.. (2000). 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Multiple Sclerosis Journal. 6(3). 148–155. 82 indexed citations
5.
Andersson, P.-B., Emmanuelle Waubant, Lauren Gee, & Donald E. Goodkin. (1999). Multiple Sclerosis That Is Progressive From the Time of Onset. Archives of Neurology. 56(9). 1138–1138. 64 indexed citations
6.
Katz, J.S., Gil I. Wolfe, P.-B. Andersson, et al.. (1999). Brachial amyotrophic diplegia. Neurology. 53(5). 1071–1071. 87 indexed citations
7.
Waubant, Emmanuelle, D Goodkin, Lauren Gee, et al.. (1999). Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology. 53(7). 1397–1397. 199 indexed citations
8.
Waubant, Emmanuelle, D Goodkin, R. Sloan, & P.-B. Andersson. (1999). A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 53(4). 874–874. 18 indexed citations
9.
Andersson, P.-B. & Donald E. Goodkin. (1997). Outcome measures in multiple sclerosis clinical trials.. PubMed. 6(3). 409–28. 3 indexed citations
10.
Andersson, P.-B. & Donald E. Goodkin. (1996). Current pharmacologic treatment of multiple sclerosis symptoms.. PubMed. 165(5). 313–7. 17 indexed citations
11.
Reid, Delyth M., V. Hugh Perry, P.-B. Andersson, & Siamon Gordon. (1993). Mitosis and apoptosis of microgliain vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience. 56(3). 529–533. 66 indexed citations
12.
Andersson, P.-B., V. Hugh Perry, & Siamon Gordon. (1992). Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system.. The Journal of Experimental Medicine. 176(1). 255–259. 137 indexed citations
13.
Perry, V. Hugh & P.-B. Andersson. (1992). The inflammatory response in the CNS. Neuropathology and Applied Neurobiology. 18(5). 454–459. 56 indexed citations
14.
Andersson, P.-B., V. Hugh Perry, & Sharon Gordon. (1992). The acute inflammatory response to lipopolysaccharide in cns parenchyma differs from that in other body tissues. Neuroscience. 48(1). 169–186. 282 indexed citations
15.
Andersson, P.-B., V. Hugh Perry, & Siamon Gordon. (1991). The CNS acute inflammatory response to excitotoxic neuronal cell death. Immunology Letters. 30(2). 177–181. 48 indexed citations
16.
Andersson, P.-B., V. Hugh Perry, & Siamon Gordon. (1991). The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience. 42(1). 201–214. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026